Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin is a globular cytoskeletal protein that exists primarily as alpha-tubulin and beta-tubulin subunits. These subunits form heterodimers that polymerize to create microtubules—hollow cylindrical structures essential for cell division, intracellular transport, maintenance of cell shape, and cellular motility. Drugs that bind tubulin and inhibit its ability to polymerize into microtubules disrupt the mitotic spindle formation required for chromosome segregation during mitosis. This mechanism is exploited in cancer therapy by agents such as colchicine and vinca alkaloids (vincristine, vinblastine), which arrest rapidly dividing cells in metaphase by destabilizing the microtubule network[1][2]. **Note:** The target name "Tubulin protein binding inhibiting microtubule polymerization" describes a mechanism rather than a canonical molecular entity or receptor. The correct target is "Tubulin protein," specifically referring to the alpha/beta tubulin dimer involved in microtubule dynamics. Therefore, this entry is marked as **is_incorrect = true** because it does not conform to standard naming conventions for molecular targets; it conflates the molecule with its pharmacological inhibition mechanism rather than specifying just the molecule itself[1][2].
Inhibition of microtubule polymerization by binding to tubulin dimers, preventing their assembly into microtubules[1][2]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin protein.